The Erythropoietin Drugs Market Demand is witnessing a remarkable surge as healthcare systems worldwide increasingly recognize the critical role of erythropoietin therapies in managing anemia. By 2035, this market is poised to reach USD 32.45 billion, with a compound annual growth rate (CAGR) of 9.68%. This growth trajectory illustrates the confluence of rising healthcare needs and...